News
6d
Exelixis Inc (EXEL) reports robust financial results driven by the cabozantinib franchise, while navigating competitive and ...
Zacks.com on MSN5d
EXEL Q2 Earnings Top, Sales Miss on Lower Collaboration RevenuesEXEL beats on Q2 earnings but misses revenues as lower collaboration income offsets strong Cabometyx sales growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback